An absence seizure is the term for a type of seizure involving staring spells. This type of seizure is a brief (usually less than 15 seconds) disturbance of brain function due to abnormal electrical activity in the brain.
Seizure - petit mal; Seizure - absence; Petit mal seizure; Epilepsy - absence seizure; Non-motor generalized seizure
Seizures result from overactivity in the brain. Absence seizures occur most often in people under age 20, usually in children ages 4 to 12.
In some cases, the seizures are triggered by flashing lights or when the person breathes faster and more deeply than usual (hyperventilates).
They may also occur with other types of seizures, such as bilateral tonic-clonic seizures (grand mal seizures), twitches or jerks (myoclonus), or sudden loss of muscle strength (atonic seizures).
Most absence seizures last only a few seconds. They often involve staring episodes. The episodes may:
Unexplained difficulties in school and learning difficulties may be the first sign of absence seizures.
During the seizure, the person may:
The person usually does not fall during the seizure.
Right after the seizure, the person is usually:
Specific symptoms of typical absence seizures may include:
Some absence seizures begin slower and last longer. These are called atypical absence seizures. Symptoms are similar to regular absence seizures, but muscle activity changes may be more noticeable.
Treatment for absence seizures includes medicines, changes in lifestyle for adults and children, such as activity and diet, and sometimes surgery. Your doctor can tell you more about these options.
Orrin Devinsky is a Neurologist and a General Surgeon in New York, New York. Devinsky has been practicing medicine for over 41 years and is rated as an Elite expert by MediFind in the treatment of Absence Seizure. He is also highly rated in 31 other conditions, according to our data. His top areas of expertise are Dravet Syndrome, Epilepsy, Seizures, Myoclonic Epilepsy, and Deep Brain Stimulation. Devinsky is currently accepting new patients.
Hal Blumenfeld is a Neurologist in New Haven, Connecticut. Blumenfeld has been practicing medicine for over 31 years and is rated as an Elite expert by MediFind in the treatment of Absence Seizure. He is also highly rated in 6 other conditions, according to our data. His top areas of expertise are Absence Seizure, Seizures, Epilepsy Juvenile Absence, Epilepsy, and Deep Brain Stimulation. Blumenfeld is currently accepting new patients.
Cian Mccafferty practices in Cork, Ireland. Mccafferty is rated as an Elite expert by MediFind in the treatment of Absence Seizure. He is also highly rated in 5 other conditions, according to our data. His top areas of expertise are Absence Seizure, Seizures, Epilepsy Juvenile Absence, Epilepsy, and Deep Brain Stimulation.
Summary: One in 10 people have a seizure during their life. Usually no cause is identified. Seizures without an identified cause are called unprovoked first seizure (UFS). Most people with UFS do not have further seizures. Being able to predict the risk of more seizures as soon as possible would help doctors decide whether to suggest treatment after UFS. Studies show that seizures are associated with chang...
Background: Electroconvulsive therapy (ECT) is used to treat people with severe depression. During ECT, the brain is given electric pulses that cause a seizure. Although it is effective, it can cause side effects, including memory loss. Researchers want to study a new way to give ECT called iLAST.
Published Date: January 23, 2022
Published By: Joseph V. Campellone, MD, Department of Neurology, Cooper Medical School at Rowan University, Camden, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Abou-Khalil BW, Gallagher MJ, Macdonald RL. Epilepsies. In: Jankovic J, Mazziotta JC, Pomeroy SL, Newman NJ, eds. Bradley and Daroff’s Neurology in Clinical Practice. 8th ed. Philadelphia, PA: Elsevier; 2022:chap 100.
Kanner AM, Ashman E, Gloss D, et al. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2018;91(2):74-81. PMID: 29898971 pubmed.ncbi.nlm.nih.gov/29898971/.
Marcdante KJ, Kliegman RM. Seizures. In: Marcdante KJ, Kliegman RM, Schuh AM, eds. Nelson Essentials of Pediatrics. 9th ed. Philadelphia, PA: Elsevier; 2023:chap 181.
Wiebe S. The epilepsies. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 375.